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IGARETTE SMOKING HAS BEEN
shown to be an important independent risk factor for development of age-related cataract. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] However, risk of cataract in individuals who quit smoking is uncertain. Some studies have found that risk of cataract remains elevated for many yearsfollowingsmokingcessation. 4, 9 Others have reported that the risk approaches the level of never smokers several years after quitting smoking, suggesting that damage to the lens may be reversible. 5, 6, 10 In a report from the Physicians' Health Study I, based on the first 5 years of follow-up, we showed that current smokers of 20 or more cigarettes per day, compared with never smokers, had a 2-fold increased risk of cataract, while past smokers had a 15% increased risk of cataract that was not statistically significant. 8 In this article, we extend these findings by including cataracts diagnosed during more than 13 years of follow-up and by examining the relationship of time since quitting smoking with risk of cataract following smoking cessation.
METHODS
The Physicians' Health Study I was a randomized, double-blind, placebocontrolled trial of low-dosage aspirin and ␤-carotene in the prevention of cardiovascular disease and cancer among 22071 US male physicians aged 40 to 84 years in 1982. At baseline, participants completed mailed questionnaires that included information on history of and risk factors for cataract and whether they had ever smoked cigarettes regularly (grouped as never, past, or current).
Current smokers were asked how many cigarettes per day, on average, they smoked. On the 60-month follow-up questionnaire, subjects were asked to give a detailed smoking history, including their age at starting and quitting smoking. The 60-month questionnaire also requested information on amount of cigarettes smoked for both current and past smokers. Subjects were asked, "When you smoke (or smoked), on average how many cigarettes per day do (did) you smoke (Ͻ1 pack per day, 1 pack per day, 1-2 packs per day, or Ն2 packs per day)?" Information on new occurrence of cataract and cataract extraction was ascertained on yearly follow-up questionnaires.
This investigation includes the 20907 participants who had no diagnosis of cataract and provided information about cigarette smoking at baseline.
Following a report of a cataract diagnosis or extraction and receipt of written consent to obtain medical records pertaining to cataract, treating ophthalmologists or optometrists were contacted by mail to obtain information about presence of lens opacities, date of diagnosis, visual acuity loss, cataract extraction, other ocular abnormalities that could explain visual acuity loss, cataract type, and etiology.
End points were incident cataract and extraction of incident cataract. Cataract was defined as a self-report confirmed by medical record review initially diagnosed after randomization, age-related in origin, with best-corrected visual acuity of 20/30 or worse attributable to cataract. This article includes all available data through December 1997.
Cox proportional hazards models were used to assess the effect of smoking cessation on risk of cataract while simultaneously controlling for other cataract risk factors. Models were fit using current smokers as the reference category, as recommended in the 1990 surgeon general's report on smoking cessation. 12 In initial analyses, subjects were classified as never, past, or current smokers, based on data reported at baseline. We then examined the risk of cataract in past smokers who quit less than 10 years, 10 to less than 20 years, or 20 or more years before study entry in models that controlled for other cataract risk factors and for age at starting smoking or number of cigarettes consumed per day. Finally, we examined the independent contributions of total cumulative dose and smoking status (past vs current) to risk of cataract in ever smokers. The significance of variables was tested using the likelihood ratio test. To calculate total cumulative dose, subjects were classified by pack-years of smoking. We used baseline data on amount smoked for current smokers and 60-month follow-up questionnaire data on amount smoked for past smokers (since information on amount smoked was collected only for current smokers at baseline) to calculate packyears of smoking at baseline. We defined pack-years as the number of years of smoking times the number of packs of cigarettes smoked per day.
Cigarette smoking is associated with an increased risk of age-related macular degeneration (AMD) in this population, 13 and subjects with cataract may have been identified because of presence of AMD. Therefore, we also conducted analyses in which we included diagnosis of AMD as a time-varying covariate. Relative risk (RR) estimates derived from these models, however, were not materially different from estimates derived from models that were unadjusted for diagnosis of AMD (data not shown).
RESULTS
At baseline, 11% of the study participants were current smokers, 39% were past smokers, and 50% were never smokers. Compared with current smokers, past smokers were older and, after adjusting for age, tended to report less alcohol use, diabetes, parental history of myocardial infarction, and multivitamin use, but more physical activity (TABLE 1). Mean age at starting smoking was similar in past and current smokers, but total pack-years of smoking at baseline were almost 2-fold greater in current smokers than in past smokers (35.8 vs 20.5 pack-years) ( Table 1) .
During an average of 13.6 years of follow-up, there were 2074 agerelated cataract diagnoses and 1193 cataract extractions confirmed by medical record review. Risk of cataract in past smokers was intermediate between current and never smokers. Compared with men who continued to smoke, men who had quit less than 10 years before study entry had an approximately 20% reduced risk of cataract diagnosis after adjustment for other cataract risk factors and average number of cigarettes smoked per day or age at starting smoking (TABLE 2). There was little additional reduction in risk in men who had quit 10 or more years before study entry. For cataract extraction, there was an approximately 25% reduced risk in men who had quit less than 10 years before study entry vs those who continued to smoke. Similarly, there appeared to be little additional reduction in risk in men who quit smoking 10 or more years before study entry. For both end points, risk of cataract in longterm quitters appeared to remain slightly (but not significantly) elevated compared with risk in never smokers.
When we examined the independent contributions of total cumulative dose and smoking status to risk of cataract among ever smokers, the bestfitting multivariate model included only a term for total cumulative dose (RR, 1.07; 95% CI, 1.04-1.10). Thus, there was a 7% increased risk of cataract associated with a 10-pack-year increase in smoking exposure. Addition of a 2-level categorical term for smoking status (past vs current, RR, 0.85; 95% CI, 0.73-1.00) was suggestive of an independent benefit associated with being a past smoker, but did not significantly improve the fit of the model based on the likelihood ratio test (P = .08). For cataract extraction, the best-fitting model did include a term for smoking status (past vs current, RR, 0.80; 95% CI, 0.65-0.97) in addition to a continuous term for total pack-years of smoking (for a 10-pack-year increase, RR, 1.05; 95% CI, 1.01-1.09), suggesting a benefit for past smokers that was independent of total cumulative dose. There were no significant interactions between smoking status and cumulative dose for either end point.
COMMENT
In this cohort of US male physicians, the risk of cataract in past smokers appeared to be intermediate between the risks in continuing smokers and never smokers. Compared with those who continued to smoke, a lower risk of cataract in past smokers was apparent in men who had quit smoking less than 10 years before study entry, with little additional reduction in risk associated with longer time since quitting smoking. The lower risk in past smokers was due primarily to their lower total cumulative dose of smoking, although there was evidence of a benefit of quitting smoking that was independent of cumulative dose, suggesting that some smoking-related damage in the lens may be reversible on smoking cessation.
Several previous studies have examined the risk of cataract in former smokers. A population-based, crosssectional survey of 838 Maryland watermen indicated that the risk of pure nuclear opacities decreased during the first 10 years following smoking cessation and continued to decrease with longer time since quitting. 5 A more recent analysis of prospective data from that cohort showed that past smokers and never smokers had similar progression rates of nuclear sclerosis during 5 years of follow-up. 10 In the Lens Opacities Case-Control Study, there was an increased risk of nuclear sclerosis among current smokers (RR, 1.7; 95% CI, 1.0-2.8), but none was reported for past smokers. 6 The results of 2 other studies suggest that the risk of cata- ract, especially among heavy smokers, decreases little, if at all, following smoking cessation. In the City Eye Study, a cross-sectional analysis of baseline data showed that past heavy smokers (Ն25 cigarettes per day) had a risk of nuclear sclerosis (RR, 2.6; 95% CI, 1.4-5.0) comparable in magnitude with the risk in current heavy smokers (RR, 2.9; 95% CI, 1.4-5.9). 4 There was no increased risk of nuclear sclerosis in past moderate (15-24 cigarettes per day) or past light (1-14 cigarettes per day) smokers in that study. In the Nurses Health Study, the overall RR for past smokers vs never smokers was 1.0 (95% CI, 0.8-1.2). However, the risk of cataract in past smokers who had smoked at least 35 cigarettes per day (RR, 1.8; 95% CI, 1.1-2.9) was similar to the risk in current heavy smokers (RR, 1.6; 95% CI, 1.0-2.7), and these risks remained comparable after 10 or more years following smoking cessation. 9 Our findings in the Physicians' Health Study I are in broad agreement with previous studies that indicate a reduced risk of cataract in past smokers compared with current smokers, due primarily to lower total cumulative dose in past smokers. We found no evidence to indicate that even the most heavily exposed men in our population did not benefit from smoking cessation. However, our data show that compared with men who have never smoked, past smokers appear to have a slightly elevated risk of cataract that may persist for years following smoking cessation.
Several possible limitations of the study should be considered. The prospective study design reduces the possibility of bias in reports of cigarette smoking or other potential risk factors according to disease outcome. Random misclassification of cigarette exposure is a possibility, but would tend to underestimate any true association between cigarette smoking and cataract. Random misclassification of cataract would also underestimate any true effect of smoking, but was minimized by the use of medical records to confirm the selfreports. Nonrandom misclassification of cataract is unlikely since medical records were reviewed without knowledge of participants' exposure status. Morbidity follow-up was more than 99% complete (through December 1997) and medical records were obtained for 92% to 94% of current, past, and never smokers who reported cataract. Thus, bias due to incomplete follow-up is not likely to distort these results.
Mechanisms linking cigarette smoking and cataract have been described, including a direct effect on the lens, 14, 15 as well as indirect effects on antioxidant levels [16] [17] [18] [19] [20] and levels of endogenous proteolytic enzymes, thought to be important for removal of damaged protein from the lens. 21 Stopping smoking may alleviate further direct damage to lens proteins and, perhaps, allow reversal of some of the early deleterious effects of smoking.
Cataract is a leading cause of visual impairment in the United States and represents a major drain on health care resources.
22 Approximately 1.35 million cataract operations are performed yearly in the United States at an estimated cost of $3.5 billion. 22 Given these considerations, recognition that smoking is an important, avoidable cause of age-related cataract can be expected to have major public health implications. The data presented extend previous findings by demonstrating that smoking cessation reduces the risk of cataract primarily by limiting total smoking-related damage to the lens. The data also indicate that some damage in the lens may not be reversed with smoking cessation, underscoring the importance of early cessation of smoking and, preferably, the avoidance of smoking altogether.
